Published “Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial” in The Lancet — cited 3,435 times.
- #crossref
- #research
- #work